Literature DB >> 14551486

Age dependence of in vitro survival of meningococci in whole blood during childhood.

Catherine A Ison1, Natasha Anwar, Michelle J Cole, Andrew J Pollard, Sarah L Morley, Katy Fidler, Colin Sandiford, Julia Banks, Simon J Kroll, Michael Levin.   

Abstract

OBJECTIVES: To determine the association between the ability of a different strains of meningococci to survive in whole blood and the age of the donor.
METHODS: A panel of serogroup B and a serogroup C strain of Neisseria meningitidis was tested in an ex vivo whole blood model. Blood from 81 healthy children and 20 adults and from children during convalescence from serogroup B (55 patients) or serogroup C (43 patients) meningococcal infection was assessed.
RESULTS: Age-dependent acquisition of whole blood killing of serogroup B and C bacterial isolates was demonstrated in healthy children with an inverse relationship to the reported incidence of disease. After infection with serogroup B or C meningococci, evidence of whole blood killing of the bacteria was found even in blood from children <2 years of age, the survival of a serogroup B strain, MC58, being reduced compared with that in healthy children (median, 64% compared with 194.5% survival at 90 min). In both affected children and controls, there was a significant correlation between whole blood killing of strain MC58 and of other serogroup B and C meningococci.
CONCLUSIONS: The whole blood model measures both humoral and cellular mechanisms responsible for the bactericidal activity of blood. The model was first described 80 years ago, but this is the first description of its age dependency. Acquisition of bactericidal activity was more rapid in children infected and is directed at various strains of meningococci, indicating the presence of a cross-reactive antigen(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551486     DOI: 10.1097/01.inf.0000091283.10199.dc

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.

Authors:  Jo Anne Welsch; Dan Granoff
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

Review 2.  Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.

Authors:  Dan M Granoff
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

3.  Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.

Authors:  Joyce S Plested; Jo Anne Welsch; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2009-04-01

4.  A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.

Authors:  Erika van der Maten; Marien I de Jonge; Ronald de Groot; Michiel van der Flier; Jeroen D Langereis
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.